Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct 1:11:4.
doi: 10.1186/1758-2652-11-4.

Prevention of the sexual transmission of HIV-1: preparing for success

Affiliations

Prevention of the sexual transmission of HIV-1: preparing for success

Myron S Cohen et al. J Int AIDS Soc. .

Abstract

There are four opportunities for HIV prevention: before exposure, at the moment of exposure, immediately after exposure, and as secondary prevention focused on infected subjects. Until recently, most resources have been directed toward behavioral strategies aimed at preventing exposure entirely. Recognizing that these strategies are not enough to contain the epidemic, investigators are turning their attention to post-exposure prevention opportunities. There is increasing focus on the use of ART-either systemic or topical (microbicides)-to prevent infection at the moment of exposure. Likewise, there is growing evidence that ART treatment of infected people could serve as prevention as well. A number of ongoing clinical trials will shed some light on the potential of these approaches. Above all, prevention of HIV requires decision-makers to focus resources on strategies that are most effective. Finally, treatment of HIV and prevention of HIV must be considered and deployed together.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HIV Prevention opportunities, adapted from[4].
Figure 2
Figure 2
Infectiousness and susceptibility, adapted from[16].
Figure 3
Figure 3
HIV-1 Transmission Event, adapted from[25].
Figure 4
Figure 4
Male and Female GT ART, reproduced with permission from[46].

Similar articles

  • Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ, Uckun FM. D'Cruz OJ, et al. Curr Pharm Des. 2004;10(3):315-36. doi: 10.2174/1381612043386374. Curr Pharm Des. 2004. PMID: 14754390 Review.
  • Tuberculosis.
    Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Bloom BR, et al. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
  • Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus.
    Blocker ME, Cohen MS. Blocker ME, et al. Infect Dis Clin North Am. 2000 Dec;14(4):983-99. doi: 10.1016/s0891-5520(05)70143-4. Infect Dis Clin North Am. 2000. PMID: 11144648 Review.
  • Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A. Gaym A. Ethiop Med J. 2006 Oct;44(4):405-15. Ethiop Med J. 2006. PMID: 17370443 Review.
  • HIV/AIDS Comorbidities: Impact on Cancer, Noncommunicable Diseases, and Reproductive Health.
    Casper C, Crane H, Menon M, Money D. Casper C, et al. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 3. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 3. PMID: 30212097 Free Books & Documents. Review.

Cited by

References

    1. UNAIDS. AIDS Epidemic Update. Vol. 11. Geneva, Switzerland: UNAIDS; 2007.
    1. Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, Hearst N, Wamai RG, Kahn JG, Walsh J. Public health. Reassessing HIV prevention. Science. 2008;11(5877):749–750. doi: 10.1126/science.1153843. - DOI - PMC - PubMed
    1. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: what will make them work better? Lancet. 2008. in press . - PMC - PubMed
    1. Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest. 2008;11(4):1244–1254. doi: 10.1172/JCI34706. - DOI - PMC - PubMed
    1. Sepulveda J, Carpenter C, Curran J, Holzemer W, Smits H, Scott K, Orza M. PEPFAR Implementation: Progress and Promise. Washington, D.C.: National Academies Press; 2007.

LinkOut - more resources